In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff. Click to learn more
Log In

At the American College of Cardiology’s 2019 Scientific Sessions, both Edwards and Medtronic announced the results of studies demonstrating transcatheter aortic valve replacement (TAVR) to be a safe and feasible alternative to surgery for patients with a low mortality risk.

Watch this video to learn why this news will change the procedural landscape and impact supply costs. We also look at other highlights from this year’s ACC sessions, including whether the Apple Watch can effectively detect atrial fibrillation.

Related: The AUGUSTUS Study & More: Drug Developments to Watch from ACC19




This Content is provided “AS IS”, with all faults and without any warranty of any kind; any and all warranties are expressly disclaimed. No information in this Content is, or should be construed as medical advice, a guarantee of any product safety or any endorsement of any product or service; use of this Content is at your own risk. Lumere shall not be liable, in any way, for any use of this Article or decisions made and/or actions taken based upon the contents herein. Discussion of experimental uses of drugs or medical product as described in this Content is for informational purposes only, and is not to be interpreted as an endorsement or encouragement of off-label use of any product.